Relative effectiveness of additive pain interventions during vaccination in infants

Anna Taddio1, Rebecca Pillai Riddell2, Moshe Ipp2

  • 1Leslie Dan Faculty of Pharmacy (Taddio, Fletcher, Wong, McNair, Mithal), University of Toronto; Child Health Evaluative Sciences (Taddio), The Hospital for Sick Children, Toronto, Ont.; Department of Psychology (Pillai Riddell), York University, North York, Ont.; Department of Psychiatry (Pillai Riddell) and Paediatrics (Ipp), University of Toronto, Toronto, Ont.; Pediatricians (Moss, Baker, Tolkin, Malini, Feerasta, Govan), North York, Ont.; Biostatistics and Data Analysis Unit (Stephens), The Hospital for Sick Children, Toronto, Ont. anna.taddio@utoronto.ca.

Insights

Topical liposomal lidocaine, combined with video education and sucrose, effectively reduced infant pain during vaccinations. This additive pain intervention strategy improved the vaccination experience for infants and parents.

Area of Science:

  • Pediatric Pain Management
  • Vaccination Adverse Events
  • Clinical Trial Methodology

Background:

  • Vaccine injections cause pain and distress in infants, potentially leading to vaccine hesitancy.
  • Effective pain management during infant vaccinations is crucial for a positive healthcare experience.

Purpose of the Study:

  • To compare the effectiveness of additive pain interventions during infant vaccinations.
  • To evaluate combined interventions including video education, sucrose, and topical lidocaine.

Main Methods:

  • A multicenter, double-blind, randomized controlled trial involving 352 infants.
  • Infants received one of four pain management strategies: placebo, video, video+sucrose, or video+sucrose+lidocaine.
  • Infant distress was assessed using the Modified Behavioural Pain Scale during pre-injection, injection, and recovery phases.

Main Results:

  • The combination of video, sucrose, and liposomal lidocaine showed a trend towards lower needle pain scores (6.3 ± 0.8) compared to other groups (6.7 ± 0.8).
  • No significant differences in pain scores were found between groups for baseline or recovery phases.
  • Pain scores varied significantly across infant ages, with needle pain scores differing among intervention groups (p=0.003).

Conclusions:

  • Liposomal lidocaine, as part of an additive pain intervention, provided consistent analgesia during infant vaccinations.
  • This multimodal approach may help mitigate pain and distress associated with routine infant immunizations.
Abstract

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.6K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
898
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
849
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
645